Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Is exclusive Skp2 targeting always beneficial in cancer therapy?

Koutsami M, Velimezi G, Kotsinas A, Evangelou K, Papavassiliou AG, Kittas C, Gorgoulis VG.

Blood. 2008 Dec 1;112(12):4777-9. doi: 10.1182/blood-2008-06-161802. No abstract available.

2.

Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior.

Liontos M, Koutsami M, Sideridou M, Evangelou K, Kletsas D, Levy B, Kotsinas A, Nahum O, Zoumpourlis V, Kouloukoussa M, Lygerou Z, Taraviras S, Kittas C, Bartkova J, Papavassiliou AG, Bartek J, Halazonetis TD, Gorgoulis VG.

Cancer Res. 2007 Nov 15;67(22):10899-909.

3.

Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.

Pateras IS, Apostolopoulou K, Koutsami M, Evangelou K, Tsantoulis P, Liloglou T, Nikolaidis G, Sigala F, Kittas C, Field JK, Kotsinas A, Gorgoulis VG.

Int J Cancer. 2006 Dec 1;119(11):2546-56.

4.

Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpression.

Koutsami MK, Tsantoulis PK, Kouloukoussa M, Apostolopoulou K, Pateras IS, Spartinou Z, Drougou A, Evangelou K, Kittas C, Bartkova J, Bartek J, Gorgoulis VG.

J Pathol. 2006 Aug;209(4):512-21.

PMID:
16739112
5.

Genetic and molecular coordinates of neuroendocrine lung tumors, with emphasis on small-cell lung carcinomas.

Koutsami MK, Doussis-Anagnostopoulou I, Papavassiliou AG, Gorgoulis VG.

Mol Med. 2002 Aug;8(8):419-36. Review.

6.

Prognostic factors in non-small cell lung carcinoma.

Koutsami MK, Gorgoulis VG, Kastrinakis NG, Asimacopoulos PJ, Kittas C.

Anticancer Res. 2002 Jan-Feb;22(1A):347-74. Review.

PMID:
12017316

Supplemental Content

Loading ...
Support Center